References
- Biggs R., Douglas A. S., Macfarlane R G. The action of thromboplastic substances. J. Physiol. (Lond.) 1953; 122: 554
- Meier W., Moenke H., Bidwell E., Handley D. H., Macfarlane R. G., Trueta J., Elliot-Smith A., Dike G. W. R., Ash B. J. The preparation and assay of a Christmas factor (factor IX) concentrate and its use in the treatment of two patients. Brit. J. Haematol. 1961; 7: 349
- Godal H. C. A comparison of two heparin-neutralizing agents: Protamine and polybrene. Sad. J. clin. Lab. Invest. 1960; 12: 446
- Ryde C. Personal communication 1962
- Hjort P. F., Stormorken H. A study of the in vitro and in vivo effects of a synthetic heparin-like anticoagulant: dextran sulphate. Scand. J. clin. Lab. Invest. 1957; 9
- Holemans R., Vermylen C., Verstraete M. Disappearance of factor V activity after incubation of plasma with heparin and heparinoides. Thrombos. Diathes. haemorrh. 1960; 4: 301
- Lee R. S., White P. D. A clinical study of the coagulation time of blood. Amer. J. med. Sci. 1913; 145: 495
- O'Brien J. R. The effect of heparin on the early stages of blood coagulation. J. clin. Path. 1960; 13: 93
- Owren P. A. The coagulation of blood. Investigation of a new clotting factor. Thesis. Acta med. scand. 1947; 128
- Thrombotest K. A new method for controlling anticoagulant therapy. Lancet ZZ 1959; 754
- Mason M. F., Hawley G., Aas K. The control of Dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand. J. clin. Lab. Invest. 1951; 3: 201
- Rothnie N. G., Kinmonth J. B. The neutralization of heparin after perfusion. Brit. med. J. 1960; 2: 1194
- Shaneberge J. N., Sarelis A., Regan E. E. The effect om heparin on plasma thromboplastin formation. J. Lab. clin. Med. 1959; 54: 501
- Øhre-Nilsen N. Studies on blood platelets during extracorporeal circulation.